Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Melanoma, Head and Neck Cancer, Breast Cancer
Interventions: Sentinella Intraoperative imaging protocol; Device
Lead sponsor: Oncovision Inc; Industry
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Urinary Incontinence, Fecal Incontinence
Interventions: Incontinence Management System; Device
Lead sponsor: Hill-Rom; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Colorectal Neoplasm, Colonic Polyps
Interventions: Close focus HD NBI Colonoscopy System; Device
Lead sponsor: VA Palo Alto Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 558 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Palo Alto, California • Kansas City, Missouri

Conditions: Lymphoma
Interventions: aldesleukin, filgrastim, recombinant interferon gamma, carmustine, cyclosporine, cytarabine, etoposide, melphalan, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 30 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 60
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 53 more

Conditions: Perilunate Injury
Interventions: Arthroscopic surgery, Open Surgery; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diffuse Large B-cell Lymphoma
Interventions: Radiation Therapy; Radiation
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2019
U.S. locations: 3
States / cities: Durham, North Carolina • Raleigh, North Carolina

Conditions: Breast Health
Interventions: Full Field Digital Mammography, Digital Breast Tomosynthesis; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 40 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: MDD
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Neuronetics; Other
Eligibility: 12 Years to 21 Years
Enrollment: 7,690 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Malvern, Pennsylvania

Conditions: Healthy
Interventions: High-Intensity Interval Training; Behavioral
Lead sponsor: Kennesaw State University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Kennesaw, Georgia

Conditions: Cancer in Remission (Any Type or Stage), Depression, Anxiety
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Northwestern University; Other
Eligibility: 22 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gulf War Illness, Depression
Interventions: Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 3
States / cities: Palo Alto, California • San Diego, California • Decatur, Georgia

Conditions: Breast Cancer
Interventions: Dual-Energy Contrast-Enhanced (DECE) mammography, digital mammography; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Off Pump Coronary Artery Bypass Surgery
Interventions: Vacuum Stabilizer System, Vacuum Positioner System, Blower/Mister, Proximal Seal System; Device
Lead sponsor: Maquet Cardiovascular; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Stockton, California • Wausau, Wisconsin

Conditions: Parkinson's Disease, Essential Tremor
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Aurora, Colorado

Conditions: Osteo Arthritis Knee
Interventions: Ropivacaine; Drug
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Breast Cancer
Interventions: high field strength magnetic resonance imaging, magnetic resonance spectroscopic imaging, chemical exchange saturation transfer magnetic resonance imaging, diffusion-weighted magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance imaging; Procedure
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Antisocial Behavior
Interventions: Attention to Context (ATC) training, Affective Cognitive Control (ACC) training; Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Carotid Artery Disease, Carotid Artery Stenosis, Diabetes, Cognitive Dysfunction
Interventions: Carotid endarterectomy, Shunt; Procedure · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Memory
Interventions: Functional Magnetic Resonance Imaging (fMRI), Repetitive Transcranial Magnetic Stimulation (rTMS); Diagnostic Test · Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute, Perforated Appendicitis
Interventions: Irrigation with PVI, Usual care; Drug · Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 2 Years to 17 Years
Enrollment: 1,750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Primary Open Angle Glaucoma
Interventions: Life Space Questionnaire, Low Luminance Questionnaire, Contrast sensitivity under dim illumination, Visual field under dim illumination (MAIA), Macular Pigment Optical Density (MPOD), Dark Adaptation; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Dementia
Interventions: Sertraline; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment
Interventions: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (Sham); Device
Lead sponsor: University of Arizona; Other
Eligibility: 50 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Suicide
Interventions: Transcranial Magnetic Stimulation, Brief Cognitive Behavioral Therapy; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes

Incontinence Management System ICU Field Evaluation

Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Perilunate Management

Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma

Image Quality Assessment for Screening and Diagnostic Mammography

A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents

High-Intensity Interval Training and Performance

Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety

rTMS in Alleviating Pain and Co-Morbid Symptoms in Gulf War Veterans Illness (GWVI)

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study

Optimizing DBS Electrode Placement and Programming

High Versus Low Adductor Canal Block

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

Effect of Raised CBF During CEA on Cognition in DM Patients

Individualized Closed Loop TMS for Working Memory Enhancement

Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized Study

Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults

Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)

Interleaved TMS-fMRI for Hippocampal Stimulation: Modeling Dose-Response Relationship in Amnestic Mild Cognitive Impairment

Combined TMS and Brief Cognitive Behavioral Therapy to Reduce Suicide